
|Articles|March 6, 2023
Pharma Eclipses Insurance As Top Network Radio Advertiser
Advertisement
InsideRadio.com reported pharmaceutical companies have ramped up their advertising on network radio, with drug stores and pharmaceutical firms investing $150.9m in the medium for 2022, according to MillerKaplan.
The pharmaceutical segment accounted for $146.3m, up 14.1% year-over-year, while spending by drug stores plummeted 50.7% to $4.6m.
The rise was driven by companies including Pfizer, which spent $62m on network radio in 2022.
Advancements in targeting and supply-side products have made radio a more efficient channel for pharmaceutical advertisers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
5




